Seeking efficiency and innovation in syntheses of bioactive compounds
Seeking efficiency and innovation in syntheses of bioactive compounds
批准号:
8516518
负责人:
Erik J. Sorensen
金额:
$32.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2016-07-31
关键词:
Anti-Bacterial AgentsAntibioticsAntitubercular AgentsArchitectureAttentionBacterial ProteinsBiologicalBiological FactorsBiological ProcessCell NucleusChemicalsChlorineCollaborationsCollectionCommunitiesComplexCytochrome P450Cytotoxic agentDevelopmentElementsEngineeringEstradiolEstroneEvaluationExhibitsFamilyFluorineGenerationsGoalsGrantHalogensHealthHumanHydrogenLeadMalignant neoplasm of cervix uteriMetabolicMethodsMissionMolecularMulti-Drug ResistanceMycobacterium tuberculosisOrganic ChemistryOxygenPatternPharmacologic SubstanceProductionPropertyProtein Synthesis InhibitorsPublic HealthReportingResearchRibosomesScienceSteroidsStructureTherapeuticTherapeutic Agentsanalogbasebiological researchcancer cellcarbenechemical reactionchemical synthesiscytotoxicdesigndienedrug candidatedrug developmentflexibilityhuman diseaseimprovedinnovationmembermethyl groupnoveloxidationpleuromutilinprogramsresistant strainscaffoldscreening
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The mission of this research program is to apply our expertise in organic chemistry to the design and synthesis of novel anti-tubercular, antibiotic, anticancer, and steroid-based drug candidates. Each of the scientific aims of this program will seek chemical innovation in the pursuit of high profile, natural product-based targets. In Aim I, we will develop a transformative new strategy for achieving rapid and flexible syntheses of diverse collections of steroid-based pharmaceutical candidates from simple precursor fragments. Our approach is designed to provide access to many new varieties of steroids, incorporating substitution patterns that have not yet been explored in biological research. The goal of Aim II is to respond to the rising threat to public health caused by multidrug resistant strains of Mycobacterium tuberculosis and the alarming lack of new antibiotic drug candidates. Through thoughtful molecular design and chemical synthesis, we will invent new candidates for antibiotic and antitubercular drug development efforts based on the tricyclic architecture that defines the pleuromutilin class of bacterial protein synthesis inhibitors. Notably, these candidates will be engineered to exhibit enhanced metabolic stability compared to the currently known members of the pleuromutilin family. We will probe the stability, antitubercular activity, and broad-spectrum antibiotic activity of our new pleuromutilin-based compounds through research collaborations. In Aim III of this proposal, we will complete a short and innovative synthesis of the high profile natural product, maoecrystal V. Isolated in 2004, maoecrystal V has attracted significant attention from the biomedical community due to reports of its potent and selective cytotoxic activity against cervical cancer cells. We propose herein to employ the concepts and methods of chemical synthesis to gain access to significant quantities of the natural product for collaborative studies directed toward the elucidation of the mechanism of action of maoecrystal V. Our design for synthesis will also open new avenues by which to access structurally novel screening candidates incorporating key elements of the structure of maoecrystal V.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strategies and Methods for Complex Alkaloid Synthesis
-
批准号:7479167
-
项目类别:
-
资助金额:$26.95万
-
财政年份:2005
-
负责人:Erik J. Sorensen
-
依托单位:
Chemical Synthesis of Kendomycin and Garsubellin A
-
批准号:7184317
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2005
-
负责人:Erik J. Sorensen
-
依托单位:
Chemical Synthesis of Kendomycin and Garsubellin A
-
批准号:7360288
-
项目类别:
-
资助金额:$25.92万
-
财政年份:2005
-
负责人:Erik J. Sorensen
-
依托单位:
Strategies and Methods for Complex Alkaloid Synthesis
-
批准号:7251464
-
项目类别:
-
资助金额:$27.03万
-
财政年份:2005
-
负责人:Erik J. Sorensen
-
依托单位:
Chemical Synthesis of Kendomycin and Garsubellin A
-
批准号:7623852
-
项目类别:
-
资助金额:$25.92万
-
财政年份:2005
-
负责人:Erik J. Sorensen
-
依托单位:
Strategies and Methods for Complex Alkaloid Synthesis
-
批准号:7089993
-
项目类别:
-
资助金额:$27.91万
-
财政年份:2005
-
负责人:Erik J. Sorensen
-
依托单位:
Strategies and Methods for Complex Alkaloid Synthesis
-
批准号:6958051
-
项目类别:
-
资助金额:$28.65万
-
财政年份:2005
-
负责人:Erik J. Sorensen
-
依托单位:
Synthesis of Bioactive Natural Products
-
批准号:6889534
-
项目类别:
-
资助金额:$28.9万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Synthesis of inhibitors of HIV-Rev function
-
批准号:6821925
-
项目类别:
-
资助金额:$5.21万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Synthesis of Bioactive Natural Products
-
批准号:6743727
-
项目类别:
-
资助金额:$28.98万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Synthesis of Bioactive Natural Products
-
批准号:8115895
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Seeking efficiency and innovation in syntheses of bioactive compounds
-
批准号:8704331
-
项目类别:
-
资助金额:$33.34万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Seeking efficiency and innovation in syntheses of bioactive compounds
-
批准号:8901188
-
项目类别:
-
资助金额:$33.46万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Seeking efficiency and innovation in syntheses of bioactive compounds
-
批准号:8372646
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Synthesis of Bioactive Natural Products
-
批准号:7534901
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Synthesis of Bioactive Natural Products
-
批准号:6612071
-
项目类别:
-
资助金额:$15.64万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Synthesis of Bioactive Natural Products
-
批准号:7679557
-
项目类别:
-
资助金额:$31.59万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Synthesis of Bioactive Natural Products
-
批准号:7060007
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
Synthesis of Bioactive Natural Products
-
批准号:6789667
-
项目类别:
-
资助金额:$16.14万
-
财政年份:2003
-
负责人:Erik J. Sorensen
-
依托单位:
SYNTHESIS OF WS9885B, A NOVEL CYTOTOXIC TUBULIN BINDER
-
批准号:6086479
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2000
-
负责人:Erik J. Sorensen
-
依托单位:
海外基金